Stay updated with breaking news from Pharma Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The cold chain logistics market for pharmaceuticals industry is estimated to grow by USD 11.6 billion during 2022-2027. The growth momentum...
NeoGenomics (NASDAQ:NEO – Get Rating) updated its FY 2023 earnings guidance on Wednesday. The company provided EPS guidance of -$0.36–$0.30 for the period, compared to the consensus EPS estimate of -$0.42. The company issued revenue guidance of $555.00 million-$565.00 million, compared to the consensus revenue estimate of $549.82 million. Analyst Upgrades and Downgrades A number […]
NeoGenomics (NASDAQ:NEO – Get Rating) issued an update on its FY 2023 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of -$0.36–$0.30 for the period, compared to the consensus estimate of -$0.42. The company issued revenue guidance of $555.00 million-$565.00 million, compared to the consensus revenue estimate of $549.82 million. […]
/PRNewswire/ -- What is the Overview of Cell and Gene Therapy CDMO Market? Cell and gene therapies (CAGT) are used in treating various diseases like heart...
NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) has received a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are covering the firm, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1 year price objective among brokerages that […]